Ibrutinib deacryloylpiperidine |
Katalog-Nr.GC60197 |
Ibrutinib-Deacryloylpiperidin (IBT4A) ist eine Verunreinigung von Ibrutinib. Ibrutinib ist ein selektiver, irreversibler Btk-Inhibitor mit einer IC50 von 0,5 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 330786-24-8
Sample solution is provided at 25 µL, 10mM.
Ibrutinib deacryloylpiperidine (IBT4A) is an impurity of Ibrutinib[1]. Ibrutinib is a selective, irreversible Btk inhibitor with an IC50 of 0.5 nM[2].
[1]. Somana Siva Prasad, et al. A QUALITY BY DESIGN APPROACH FOR DEVELOPMENT OF SIMPLE AND ROBUST REVERSED PHASE STABILITY INDICATING HPLC METHOD FOR ESTIMATION OF IBRUTINIB AND ITS IMPURITIES. [2]. Honigberg LA, et al. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075-80.
Average Rating: 5
(Based on Reviews and 6 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *